
Prostate cancer is a significant health concern in Sub-Saharan Africa (SSA), with limited prostate-specific antigen (PSA) screening access. Alternative screening strategies and cost-effective tests are being explored to target high-risk individuals. Diagnosis is challenging due to limited diagnostic tools, often resulting in advanced-stage diagnoses. Resource limitations constrain treatment options, and cultural beliefs impact decisions.
Like
Save
Share